1. Home
  2. WFCF vs EQ Comparison

WFCF vs EQ Comparison

Compare WFCF & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$12.83

Market Cap

59.1M

Sector

Technology

ML Signal

N/A

EQ

Equillium Inc.

HOLD

Current Price

$1.09

Market Cap

57.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
EQ
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
57.8M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
WFCF
EQ
Price
$12.83
$1.09
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
3.8K
458.0K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
$4,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$0.27
52 Week High
$13.78
$2.35

Technical Indicators

Market Signals
Indicator
WFCF
EQ
Relative Strength Index (RSI) 63.28 53.63
Support Level $12.50 $0.84
Resistance Level $13.15 $0.92
Average True Range (ATR) 0.41 0.11
MACD 0.15 0.02
Stochastic Oscillator 100.00 70.11

Price Performance

Historical Comparison
WFCF
EQ

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Share on Social Networks: